Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
June 16, 2016updated 14 Nov 2021 1:37pm

M&As this week: Terumo Corporation, Trelleborg, FluoroPharma Medical

Terumo Corporation has agreed to acquire Sequent Medical for $380m.

Terumo Corporation has agreed to acquire Sequent Medical for $380m.

Of the total, $280m will be paid upon closing of the agreement and the remaining will be paid upon achieving specific commercial and development milestones.

The acquisition will help Terumo to establish and expand its growth in the neurovascular market.

Trelleborg has signed an agreement to buy Specialty Silicone Fabricators (SSF), a high-precision silicone components manufacturer for medical technology original equipment manufacturers (OEMs).

To be completed by the end of this month, the acquisition will will enable Trelleborg to strengthen its position in the life sciences market.

“The acquisition will will enable Trelleborg to strengthen its position in the life sciences market.”

Searchlight Pharma has purchased Besins Healthcare Canada, an exclusive Canadian supplier of Mona Lisa copper intrauterine devices (IUDs).

Content from our partners
“Everything is custom”: Behind the scenes of medical wire solutions
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials

New women’s healthcare products, which will complement Searchlight’s existing portfolio, will be added by the former, through the acquisition.

FluoroPharma Medical has signed a non-binding letter of intent to acquire Ground Fluor Pharmaceuticals, a medical imaging products company.

The deal will complement FluoroPharma Medical’s late-stage positron emission tomography (PET) imaging assets for the treatment of heart disease, cancer and degenerative neurological conditions.

Fukuda Denshi has signed a memorandum of understanding (MOU) to acquire Omron Colin from Omron Healthcare for $18.69m.

Through the acquisition, Fukuda Denshi will form a business partnership with the Omron Healthcare in home medical care and overseas business, while Omron will focus on the development of devices.

Upon completion of the acquisition, Omron Colin will become the subsidiary of Fukuda Denshi, which then will get access to the Omron’s products such as vital signs monitors and medical examination equipment.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy